Hard To Treat Stock Current Valuation
Valuation analysis of Hard to Treat helps investors to measure Hard To's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Total Cash From Operating Activities is likely to gain to about 791.8 K in 2024, whereas Cash is likely to drop slightly above 115.5 K in 2024. Fundamental drivers impacting Hard To's valuation include:
Enterprise Value 254.4 K | Price Sales 0.0089 |
Undervalued
Today
Please note that Hard To's price fluctuation is out of control at this time. Calculation of the real value of Hard to Treat is based on 3 months time horizon. Increasing Hard To's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hard stock is determined by what a typical buyer is willing to pay for full or partial control of Hard to Treat. Since Hard To is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hard Stock. However, Hard To's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of Hard To's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hard To's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Hard to Treat helps investors to forecast how Hard stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hard To more accurately as focusing exclusively on Hard To's fundamentals will not take into account other important factors: Hard to Treat Company Current Valuation Analysis
Hard To's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Hard To Current Valuation | 254.37 K |
Most of Hard To's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hard to Treat is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Hard to Treat has a Current Valuation of 254.37 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Hard Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hard To's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hard To could also be used in its relative valuation, which is a method of valuing Hard To by comparing valuation metrics of similar companies.Hard To is currently under evaluation in current valuation category among its peers.
Hard Fundamentals
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 254.37 K | ||||
| Shares Outstanding | 5.48 B | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 5.39 M | ||||
| Gross Profit | 1.42 M | ||||
| EBITDA | 1.03 M | ||||
| Net Income | 621.6 K | ||||
| Cash And Equivalents | 202.9 K | ||||
| Total Debt | 1.54 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 2.27 X | ||||
| Cash Flow From Operations | 655.71 K | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 54.82 K | ||||
| Total Asset | 4.56 M | ||||
| Retained Earnings | 1.4 M | ||||
| Working Capital | (508 K) | ||||
| Current Asset | 596 K | ||||
| Current Liabilities | 1.1 M | ||||
| Net Asset | 4.56 M |
About Hard To Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hard to Treat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hard To using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hard to Treat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.